Erkka Jarvinen
Helsinki, 00014, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Automated Mag-Net Enrichment Unlocks Deep and Cost-Effective LC-MS Plasma Proteomics.
Journal: Journal of proteome research
Published: December 21, 2025
Dicloxacillin and flucloxacillin inhibit hepatic uptake transporters -in vitro investigations and physiologically based pharmacokinetic modelling.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Dicloxacillin and Flucloxacillin Inhibit Hepatic Uptake Transporters-In Vitro Investigations and Physiologically Based Pharmacokinetic Modeling.
Journal: Clinical and translational science
Published: October 25, 2025
Association of Torque Teno Virus DNA Load and Tacrolimus in Peripheral Blood Mononuclear Cells of Adult Kidney Transplant Patients.
Journal: Therapeutic drug monitoring
Published: September 12, 2025
Efflux and uptake of androgen sulfates using transporter-overexpressing HEK293 cells and membrane vesicles.
Journal: Journal of pharmaceutical sciences
Published: November 08, 2024
Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration-Time Curve in Steroid-Free Kidney Transplant Patients.
Journal: Basic & clinical pharmacology & toxicology
Published: August 30, 2024
Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients.
Journal: British journal of clinical pharmacology
Published: June 20, 2024
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users.
Journal: British journal of clinical pharmacology
Published: May 16, 2024
Thermodynamic solubility measurement without chemical analysis.
Journal: International journal of pharmaceutics
Published: August 12, 2023
Evaluating Drug-Drug Interaction Risk Associated with Peptide Analogs Using advanced In Vitro Systems.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: August 02, 2023
Dicloxacillin-warfarin drug-drug interaction-A register-based study and in vitro investigations in 3D spheroid primary human hepatocytes.
Journal: British journal of clinical pharmacology
Published: January 11, 2023
Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human Hepatocytes.
Journal: Clinical pharmacology and therapeutics
Published: November 24, 2022
Last Updated: 09/26/2026